INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

Bovine papillomavirus (BPV) replication requires only two viral proteins, E1 and E2 (40), with the rest of the replication machinery supplied by the host cell (27). Both the E1 and E2 proteins are site-specific DNA binding proteins which recognize sequences in the viral origin of replication (1, 41, 42). The E2 binding site (E2BS) is a 12-bp partial palindrome (1, 22), while E1 binds to an 18-bp imperfect inverted repeat sequence (18, 19, 34). In vitro, only the E1 protein is absolutely required, indicating that the E2 protein does not supply a requisite replication function (3, 5). Instead, E2 appears to act as an auxiliary factor that interacts directly with E1 (24, 35, 44) and increases binding site specificity (5, 32). Moreover, at low protein concentrations, E2-E1 complexes facilitate loading and assembly of additional E1 molecules on the origin to form the active initiation complex (30). Initial binding of E1 induces distortion in the origin DNA that is a likely prelude to origin unwinding, and this distortion of the origin DNA is also enhanced by E2 (13, 30). Ultimately, a hexameric E1 complex with ATP-dependent helicase activity is assembled (11, 33), though the precise steps in the formation of this hexamer are undefined. E1 also interacts with several host cell proteins, including DNA polymerase  and replication protein A (4, 14, 29), and presumably recruits these host replicative factors to the viral initiation complex.

The origin binding function of E1 is central to its role in viral genomic replication. Truncation studies of the 605-amino-acid BPV E1 protein localized the DNA binding domain (DBD) of E1 (the E1DBD) to approximately amino acids 140 to 300 (21, 31). Isolated polypeptides expressing this DBD region in the absence of other E1 sequences retain origin-specific binding activity (7, 21, 31, 39). Since the ATP binding site and helicase activity map to the C-terminal portion of E1 and are not present in the DBD, neither of these activities is required for origin recognition (39). The E1DBD does retain the ability to interact with E2 protein (21), and this interaction cooperatively enhances origin binding (7). Clearly then, the E1DBD is a functional subdomain with binding properties similar to those of full-length E1 protein.

In contrast to the E2DBD, which has been crystallized and studied in detail (15-17), little is known about the structure of the E1DBD or the sequences which mediate origin binding. A previous study identified a pair of conserved, heptad repeats of hydrophobic residues from amino acids 249 to 282 (39). A triple mutant with substitutions at two of the conserved hydrophobic residues failed to bind origin DNA, consistent with a role for these elements in origin binding. However, the third mutation in this triple mutant changed a conserved proline located between the heptads to an alanine. The proline-to-alanine substitution could likely have a significant effect on protein folding in this region and makes interpretation of the role of the heptad repeats uncertain. Two additional mutants with basic residue-to-alanine substitutions in the region adjacent to the N-terminal side of the first heptad (amino acids 241 to 247) were both severely defective for origin binding, demonstrating that this hydrophilic region was critical for E1-DNA interaction. One additional mutation at a distal site, an arginine 180-to-alanine substitution, reduced E1 DNA binding activity to less than 1% of the wild-type (WT) E1 level, though this region was not investigated further (39). In the present study, the hydrophilic region that includes E1 amino acid 180 was investigated in detail and was shown to be critical for site-specific DNA binding both in vitro and in vivo. Features of this region suggest that it may be part of a recognition sequence that mediates specific contact with nucleotides in the E1BS.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Plasmids and mutant construction. The DNA fragment encoding the WT E1DBD region from amino acids 121 to 311 (E1_121-311) was amplified under standard conditions from a cloned E1 gene, using Ultma DNA polymerase (Perkin-Elmer) and primers E1AA121 (5'-GAGCTGAATTCGCTAACCGTGTTCTTACGCCC-3') and E1AA311 (5'-CGTCCGTCGACCGCGAATTTCTCGGTCTGCAAGCT-3'). The amplified product was ligated directly to pCRBLUNT (Invitrogen) and transformed into TOP10 cells (Invitrogen). A recombinant clone was identified, and the E1DBD fragment was excised from purified plasmid DNA by EcoRI digestion. The E1DBD fragment was ligated to pGEX-5X-1 DNA (Pharmacia Biotech) that had been linearized by EcoRI digestion and was transformed into TOP10F' (Invitrogen) cells. Clones were screened for the presence of the insert fragment, and a recombinant clone with the correctly oriented fragment was identified. The entire sequence of the insert fragment was determined and found to be the correct, WT sequence and to be in frame with the glutathione S-transferase (GST) coding region. This clone, designated pGEX-E1DBD, was used for the production of all point mutants. Ten individual point mutations were constructed in pGEX-E1DBD by site-directed mutagenesis using mutagenic oligonucleotides and a QuikChange mutagenesis kit (Stratagene) as specified by the manufacturer. Mutant clones were identified by direct DNA sequencing of plasmid minipreparations; for each clone, only the desired mutation was present in the E1DBD coding region.

Purification of E1DBD proteins. For expression of WT and mutant E1DBD proteins, the respective pGEX-E1DBD plasmids were transformed into Escherichia coli BL21. BL21 transformants were grown to mid-log phase at 37°C in 2XYT medium with ampicillin (50 µg/ml) and then induced by addition of isopropyl--D-thiogalactopyranoside to 1 mM. After a 2-h induction, cultures were packed in ice for 30 min and harvested by centrifugation (15 min at 10,000 × g), and the pellets were frozen at 20°C. For lysis and extraction, the cell pellets were thawed on ice, resuspended in a minimal volume of cold GST-C buffer (50 mM Tris-HCl [pH 7.9], 250 mM NaCl, 5 mM EDTA, 5 mM dithiothreitol [DTT], 10 mM phenylmethylsulfonyl fluoride [PMSF], 10% glycerol), and incubated on ice for 60 to 120 min with lysozyme at a final concentration of 0.1 mg/ml. After the lysozyme digestion, the cell suspensions were subjected to two rounds of passage through a prechilled French press cell at 16,000 lb/in² followed by addition of NP-40 to 0.1%. Alternatively, some preparations were lysed by resuspension of the original cell pellets in B-Per reagent (Pierce) followed by lysozyme treatment. To further solubilize the proteins extracted by either procedure, the extracts were sonicated twice for 15 s at maximum power with a microtip in an Ultrasonics sonicator. The extracts were clarified by centrifugation for 30 min at 20,000 × g, and the supernatants were rotated overnight at 4°C with glutathione-Sepharose beads (Pharmacia). Subsequently, the beads were collected at 4°C by centrifugation for 5 min at 500 × g and were washed twice with 10 ml of cold GST-C, three times with 10 ml of cold GST-D (50 mM Tris-HCl [pH 8.0], 200 mM NaCl, 5 mM EDTA, 5 mM DTT, 10 mM PMSF, 10% glycerol), three times with 10 ml of cold GST-E (50 mM Tris-HCl [pH 8.0], 1.0 M NaCl, 5 mM EDTA, 5 mM DTT, 10 mM PMSF, 10% glycerol), and twice with 10 ml of cold GST-C. The washed beads were incubated for 10 min at room temperature in 500 µl of GST-C with 10 mM reduced glutathione followed by centrifugation for 1 min in a microcentrifuge. The supernatant containing the GST-E1DBD fusions was collected, adjusted to a final concentration of 50% glycerol, and stored at 20°C. Protein concentration was determined by a Bradford assay (6), and purity was assessed by scanning sodium dodecyl sulfate (SDS)-polyacrylamide gels with an IS1000 digital imaging system (Innotech Corp.). For removal of the GST moiety, factor Xa cleavage was performed as specified by Pharmacia. However, GST-E1DBD was found to be much more stable in gel shift assays than the free E1DBD, and so the fusion proteins was used for all the studies reported here. Comparison of the properties of GST-E1DBD and free E1DBD will be reported elsewhere.

Probes. Two double-stranded oligonucleotide substrates, E1BS1-4 and E1BS0, were prepared for the gel mobility shift assay. E1BS1-4 corresponds to 50 bp of BPV sequence from nucleotides 7926 to 29 which includes the 18-bp E1BS and the low-affinity E2BS12. E1BS0 is a 60-bp substrate corresponding to BPV sequences 7916 to 29 with the 18-bp E1BS replaced by an unrelated 18-bp palindromic sequence. Each of these double-stranded oligonucleotides was prepared by incubating equal molar amounts of the following complementary single-stranded oligonucleotides at 70°C for 5 min and then slow cooling to room temperature: E1BS1-4U (5'-TAATTGTTGTTAACAATAATCACACCATCACCGTTTTTTC-3') plus E1BS1-4L (5'-TGATGGTGTGATTATTGTTAACAACAATTATTCACTGGGA-3'); and E1BS0U (5'-TATCACACCGACTGTGAGCACACACCATCACCGTTTTTTC-3') plus E1BS0L (5'-TGCTCACAGTCGGTGTGATATTCACTGGGAAAAAATACAT-3'). The hybridized oligonucleotides have 5' overhangs which were subsequently radiolabeled and made blunt by incubating 1 pmol of substrate in 12.5 mM Tris-HCl (pH 7.2), 5 mM MgCl₂, 10 µM DTT, 32 µM each dATP, dGTP, and dTTP, 0.33 µM [-³²P]dCTP, and 2 U of Klenow polymerase for 60 min at 25°C followed by addition of 32 µM dCTP and incubation for another 10 min. Full-length, radiolabeled, double-stranded substrates were purified by excision and elution from 12% nondenaturing Tris-borate-EDTA gels into gel shift assay buffer (20 mM potassium phosphate [pH 7.0], 100 mM NaCl, 1 mM EDTA, 0.1% NP-40, 10% glycerol).

Gel mobility shift assay. Mobility shift assays were performed basically as described by Chen and Stenlund (7). Purified WT or mutant GST-E1DBD proteins were incubated with 2.5 fmol of radiolabeled substrate and 20 ng of pUC18 DNA in 10-µl reaction mixtures consisting of gel shift assay buffer supplemented to a final concentration of 5 mM DTT and 0.07% bovine serum albumin. Samples were incubated for 30 min at 25°C and then loaded onto 8% polyacrylamide gels in 0.5× Tris-borate-EDTA buffer. The 10× Tris-borate stock used for both the gel and the tank buffer was adjusted to pH 7.5, as this pH provided better resolution of protein-DNA complexes. Gels were electrophoresed at 100 V for 4 to 5 h. Dried gels were visualized and quantitated with a Molecular Dynamics PhosphorImager.

Yeast one-hybrid system. Plasmid p53BLUE (Clontech) contains three tandem copies of the p53 binding site (p53BS) inserted into a minimal yeast promoter (P_CYC1) upstream of the lacZ gene in plasmid pLacZi. A similar E1 reporter plasmid was constructed by cloning a double-stranded oligonucleotide consisting of three tandem copies of the 18-bp E1BS into the P_CYC1 region of pLacZi. The sequence of the resultant recombinant, designated pLacZi-E1BST, was confirmed by DNA sequencing. Purified p53BLUE and pLacZi-E1BST DNAs were linearized by NcoI digestion to promote vector integration and transfected into Saccharomyces cerevisiae YM4271 by the polyethylene glycol-lithium acetate procedure (12). Transformants were selected on minimal medium lacking uracil and were passaged several times on this medium to eliminate cells harboring unintegrated vector. The resulting yeast reporter strains containing either the integrated p53BS promoter-lacZ gene or the E1BST promoter-lacZ gene were designated p53BS-LACZ and E1BST-LACZ, respectively. Purified plasmid DNAs encoding the various GAL4 AD fusions were transfected into both of the reporter strains, and transformants were isolated on minimal medium lacking uracil and leucine.

Western blots. Whole-cell extracts were prepared from the yeast transformants by freeze-thawing cell pellets three times and then boiling them for 10 min in cracking buffer (40 mM Tris-HCl [pH 6.8], 0.1 mM EDTA, 8 M urea, 5% SDS, 0.04% bromophenol blue, 0.88% -mercaptoethanol, 0.077% PMSF). Equivalent amounts of protein from each sample were electrophoresed on a 12% polyacrylamide gel, and the proteins were electrophoretically transferred to a Protran nitrocellulose membrane (Schleicher & Schuell) as previously described (21). The blots were probed with a 1/1,000 dilution of anti-GAL4 AD (Upstate Biotechnology) and visualized by enhanced chemiluminescence with Super Signal (Pierce).

-Galactosidase assays. Two procedure were used for assessing the interaction of AD fusion protein with the E1BST or p53 promoter in the yeast reporter strains, a colony lift filter assay, and a liquid culture CPRG (chlorophenol red--D-galactopyranoside) assay. Both assays were performed as described in the Clontech Yeast Protocols Handbook. A brief description of each assay follows.

(i) Colony-lift filter assay. Transformants were inoculated onto an appropriate selective medium and grown for 2 to 3 days at 30°C until colonies were 1 to 2 mm in diameter. Colonies were replica lifted onto Whatman filter paper and lysed by freezing in liquid nitrogen followed by a thaw at room temperature. Subsequently the filter was wetted by incubation on top of a second filter soaked in Z buffer (50 mM sodium phosphate [pH 7.0], 10 mM KCl, 1 mM MgSO₄, 0.27% -mercaptoethanol) with 330 µg of X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside) per ml. Development of blue color was monitored visually, and the filter was photographed with an IS1000 digital imaging system (Innotech).

(ii) Liquid culture CRPG assay. Overnight cultures were grown in the appropriate selective medium for each transformant, and the optical density at 600 nm was recorded for later normalization. Cultures (1.5 ml) were harvested by centrifugation in microcentrifuge tubes, washed one time with buffer 1 (10 mM HEPES [pH 7.3], 150 mM NaCl, 0.065% L-aspartate, 1% bovine serum albumin, 0.05% Tween 20), and resuspended in 300 µl of buffer 1. Cells were lysed by three cycles of alternating between liquid nitrogen and a 37°C water bath. Aliquots of 100 µl of lysed cells were mixed with 700 µl of buffer 1 containing 2.23 mM CPRG and vortexed thoroughly. Samples were incubated at room temperature until visible color formation was observed or for up to 3 h. After color formation, or at 3 h if no color was observed, the reactions were stopped by addition of 500 µl of 3 mM ZnCl₂. Cell debris was removed by centrifugation for 1 min in a microcentrifuge, the optical density at 578 nm of the supernatants was read for each sample, and the -galactosidase units were calculated. All samples were assayed in triplicate, and the values reported are the average.

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

Conservation of hydrophilic domains in the E1DBD. We previously showed that the origin-specific DNA binding activity of the BPV E1 protein resides in the E1_121-311 fragment and that this isolated polypeptide retained site-specific recognition function (21). To initiate a functional study of the E1DBD, the primary sequence was examined for physical features. Hydropathy plots of the BPV E1DBD were prepared by using six different algorithms. All six plots were very similar (data not shown) and revealed three subregions with a high degree of intrinsic hydrophilicity, possibly reflecting accessible sequences capable of interacting with origin nucleotides. In the Kyte-Doolittle plot shown in Fig. 1A, the hydrophilic regions are designated HR1, HR2, and HR3. Given the cross-species functional conservation of E1 proteins (2, 8, 38) and the sequence conservation of the E1BS among different papillomaviruses (18), it was likely that subregions of the E1DBD critical for origin interaction would show some conservation of overall properties and specific primary amino acid sequence. Consequently, similar examination of hydropathy plots was conducted for the predicted DBDs of eight human papillomavirus (HPV) E1 proteins (Table 1). All eight HPV E1 proteins had significant hydrophilic character in the regions corresponding to HR1 and HR3 of BPV E1, while only three of the eight were hydrophilic in the region corresponding to HR2. This conservation of HR1 and HR3 implicates them both as potentially important for E1 DNA function, while HR2 may be of lesser or no significance. Consistent with this prediction, amino acids within HR3 have already been shown to be critical for origin binding by BPV E1 (39). HR1 has not been thoroughly investigated, although mutation of amino acid 180 at the N-terminal boundary of HR1 dramatically reduced the origin binding ability of E1 in an earlier study (39).

View larger version (28K): [in this window] [in a new window]   FIG. 1.   Sequence features of the E1DBD. (A) Kyte-Doolittle hydropathy plot of the BPV E1121-311 protein. There are three major hydrophilic peaks, designated HR1, HR2, and HR3. HR1 and HR3 are conserved among papillomavirus E1 proteins, and HR2 is nonconserved. Mutations previously shown to impair E1 DNA binding (39) are marked with asterisks. Numbered vertical arrows indicate the amino acid number of lysine residues mutated to alanine in this study. (B) Amino acid conservation and the relative hydrophilicity of the flanking sequence regions for each lysine analyzed.

Charge-to-alanine mutations identify critical amino acids for E1DBD origin recognition function. To investigate the contribution of HR1 to origin binding, lysine-to-alanine mutations were constructed at conserved residues 183 and 186 in the context of the isolated E1DBD polypeptide (Fig. 1B). Additional lysine-to-alanine mutations were created elsewhere in the DBD at both conserved and nonconserved residues located in sequence contexts of varying hydrophilicity. Each mutant E1DBD protein was expressed as a GST fusion and affinity purified to greater than 90% homogeneity (Fig. 2). The purified proteins were assayed for in vitro DNA binding activity using a gel shift assay with short (50- or 60-bp) double-stranded oligonucleotides as the substrates (Fig. 3). Oligonucleotides of this length were previously shown to be sufficient for efficient binding of E1 protein (18). The binding test substrate contained the authentic BPV origin sequence consisting of the AT-rich element, the E1BS, and the low-affinity E2BS12, while the control substrate was identical except that the 18-bp E1BS was replaced with an unrelated palindromic sequence.

View larger version (47K): [in this window] [in a new window]   FIG. 2.   Analysis of purified WT and mutant GST-E1DBD proteins. Each protein was expressed and purified on glutathione-Sepharose as described in Materials and Methods; 100 ng of each protein was electrophoresed on an SDS-10% polyacrylamide gel and then stained with Coomassie blue. The molecular masses of the marker proteins (lane M) are indicated in kilodaltons.

View larger version (51K): [in this window] [in a new window]   FIG. 3.   DNA binding by WT and mutant E1DBD proteins. (A) Gel mobility shift assays of WT and mutant E1DBD proteins. Each protein was assayed at 37.5 and 150 ng. Lanes marked  had no E1DBD added to the reaction and show the input unbound substrate; lanes 1, 2, 11, and 12 contain reactions using the E1BS0 substrate that lacks the E1BS, while all the other lanes have the complete origin substrate, E1BS1-4. (B) Quantitation of the binding results from panel A. The total amount of bound oligonucleotide was determined for the 37.5- and 150-ng samples with a PhosphorImager. The value for WT E1DBD was set as 100%, and the others are expressed relative to this value. Shown are the average results for the 150-ng samples from two experiments; error bars for the WT and 279A samples are too small to be seen. The relative results were similar with the 37.5-ng samples (not shown).

Both full-length E1 and the E1DBD exhibit site-specific DNA binding activity in vivo. The above results, as well as previously published reports of E1 DNA binding, were all in vitro studies of E1-DNA interactions. Little is known about the interaction of the E1 protein with its binding site in an in vivo context where the host cell milieu might influence E1 binding activity. In vivo transient replication assays are sensitive to E1 binding ability but are not useful for direct comparison of mutant binding activities since each mutation may also affect other E1 replication functions. Consequently, to evaluate the DNA binding activity of E1 protein in vivo more directly, we developed a yeast one-hybrid assay. An E1 reporter strain, designated E1BST-LACZ, was constructed with three tandem copies of the 18-bp E1BS integrated into the yeast genome within a minimal promoter sequence adjacent to a lacZ gene. The control strain had a similar organization except that it contained three copies of a p53BS rather than the E1BS and was designated p53BS-LACZ. Both the reporter and control strains were transfected with a series of plasmids expressing various fusions between the GAL4 AD and either p53 or E1. Transformants were isolated and replated on selective medium, and the colonies were assayed for -galactosidase activity by an X-Gal overlay procedure (Fig. 4). Both the E1BST-LACZ and the p53BS-LACZ reporter strains expressing the AD protein alone produced no detectable -galactosidase, and the colonies remained white even after overnight incubation with X-Gal. The absence of -galactosidase activity demonstrated the extremely low endogenous expression from either the E1BS promoter or the p53BS promoter and confirmed that the AD alone showed no interaction with these promoter elements.

View larger version (28K): [in this window] [in a new window]   FIG. 4.   Yeast one-hybrid analysis of E1 DNA binding in vivo. Six GAL4AD vectors expressing the AD alone or as a fusion with E1 [AD-E1(F), forward clone; AD-E1(R), reverse clone], E1DBD [AD-E1DBD, forward clone; AD-E1DBD(R), reverse clone], or p53 (AD-p53) were transfected into both the E1BST-LACZ and p53BS-LACZ reporter strains. Individual transformants were regrown on selective medium for 48 h and photographed with an IS1000 digital imaging system (Colonies). The colonies themselves are actually white but appear darkish in the photograph. The colonies were replica transferred to filter paper and tested for -galactosidase activity with the colony lift filter assay as described in Materials and Methods. The results of the -galactosidase (-gal) assay are shown in the right two columns. Three colonies turned blue; these three -galactosidase-positive clones appear dark in the photo, while the white colonies are not visible.

HR1 is critical for E1 DNA binding in vivo. Our in vitro results with the E1DBD identified sequences in HR1 as critical for E1-E1BS interaction. To examine the importance of this region in vivo, the E1 K183A mutation was constructed in the AD-E1DBD fusion for analysis in the one-hybrid system. As a control, the K157A mutation, which had no effect on E1DBD binding in vitro, was also transferred to the AD-E1DBD protein. Each mutant vector was transfected into both the E1BST-LACZ and p53BS-LACZ strains, and 10 transformants from each set were tested for -galactosidase activity (Fig. 5A). All 10 transformants expressing AD-E1DBD_K157A in the E1BST-LACZ strain were -galactosidase positive within 1 h; however, the AD-E1DBD_K183A transformants remained white for up to 8 h. After overnight incubation, the AD-E1DBD_K183A transformants exhibited faint blue color indicative of very low level of -galactosidase expression. Neither the AD-E1DBD_K157A nor the AD-E1DBD_K183A transformants produced any detectable -galactosidase activity in the p53BS-LACZ strain, even after overnight incubation.

View larger version (28K): [in this window] [in a new window]   FIG. 5.   In vivo activity of E1DBD mutants. (A) The E1 K157A and K183A mutations were constructed in the AD-E1DBD background and transfected into both the E1BST-LACZ and p53BS-LACZ reporter strains. Ten transformants from each transfection were picked onto a grid plate (1-10, E1DBDK157A/E1BST-LACZ; 11-20, E1DBDK157A/p53BS-LACZ; 21-30, E1DBDK183A/E1BST-LACZ; 31-40, E1DBDK183A/p53BS-LACZ) and assayed for -galactosidase activity as in Fig. 4. -Galactosidase-positive, blue colonies (1-10) appear dark in this photo, while the negative, white colonies (11-40) are not visible. (B) Quantitative -galactosidase assay for representative transformants from panel A. The reporter strains, E1BST-LACZ (designated E1BST) and p53BS-LACZ (designated p53BS), expressing either AD-E1DBDK175A (K157A bars), AD-E1DBDK183A (K183A bars), or the WT AD-E1DBD fusion (WT bars) were grown in liquid medium and assayed for -galactosidase activity as described in Materials and Methods. (C) Western blot of the mutant transformants used in panel B. Cell extracts were prepared, electrophoresed on an SDS-10% polyacrylamide gel, transferred, and probed with an anti-AD serum. Lane 1 is a control extract from the E1BST-LACZ strain without an AD expression vector; lanes 2 to 5 are the four transformants of the two reporter strains with the E1DBD K157A or K183A mutations as indicated. The arrow marks the AD-E1DBD fusion protein.

Orientation of the critical residues in HR1. The in vitro and in vivo studies implicated HR1 as critical for DNA binding activity of the BPV E1 protein. Projection of this region of E1 in a helical wheel format revealed an extremely hydrophilic face which included all three of the residues whose mutation abolished site-specific DNA binding: K180, K183, and K186 (Fig. 6). All three of these residues also are highly conserved in E1 proteins among all papillomavirus groups, which supports a critical functional role for this region. To further evaluate the possible importance of this hydrophilic surface, additional mutations were constructed. In the helical projection, threonine 187 lies on the hydrophilic face between critical residues R180 and K183, while threonine 188 is on the opposing half of the helix. Thus, these two threonines which are adjacent in the primary sequence are potentially located in very different environments with respect to possible DNA interaction. Supporting this possible functional difference, threonine at the position corresponding to amino acid 187 in BPV E1 is absolutely conserved whereas the 188 position is variable. However, there are also conserved residues on the opposing face such as tryptophan 192 and aspartic acid 185. To determine if a conserved residue on this opposing face contributes significantly to DNA binding activity, D185 was chosen for analysis since it is located within the short stretch of critical primary sequence defined by inactivating mutations (residues 180 to 186) yet projects to the opposite face from these essential residues. Each of these three residues, D185, T187, and T188, was mutated to an alanine in the context of the E1DBD protein and then tested for in vitro DNA binding activity (Fig. 7). Mutation of T187 completely abolished DNA binding activity (<2% of the WT level), while the nonconserved T188 mutation showed only a modest 20 to 40% reduction in origin binding. The D185A mutant was more impaired than the T188 mutant but still exhibited 30 to 50% of WT binding activity in repeated trials, and it was substantially more active than the T187A mutant. These result are consistent with the helical wheel prediction that the amino acids critical for DNA binding in HR1 are located on a common surface. The greater impact of the D185A mutation on binding than of the T188A mutation may reflect the effect of charge loss on overall structure in this region.

View larger version (22K): [in this window] [in a new window]   FIG. 6.   Helical projection and conservation of amino acids in HR1. Amino acids 176 to 193 of BPV E1 protein are displayed on the left in a helical wheel projection. The horizontal line divides the helix into two halves: an upper, highly basic, hydrophilic face, and a lower, more hydrophobic face. Lysine and arginine residues shown to be critical for DNA binding activity are marked with asterisks. The arrows indicate the two consecutive threonines and the aspartic acid that are functionally evaluated in Fig. 7. On the right is a comparison of the BPV E1 sequence from amino acids 176 to 193 aligned with the corresponding regions from the papillomavirus groups A to E and unclassified. The sequence shown for each papillomavirus group is the consensus sequence for these BPV E1-equivalent regions. Numbered residues refer to the BPV E1 amino acid number. Boxes indicate residues that are absolutely conserved with the exception of positions 183 and 185, which diverge in the group C and group B sequences, respectively.

View larger version (40K): [in this window] [in a new window]   FIG. 7.   DNA binding activity of aspartic acid 185, threonine 187, and threonine 188 mutants. (A) D185, T187A, and T188A mutations were constructed into the E1DBD protein. Purified mutant and WT proteins were tested for origin binding activity by the mobility shift assay described in the legend to Fig. 3 with the complete origin oligonucleotide, E1BS1-4, as the substrate. The series of three lanes for each sample contained 20, 40, and 80 ng of protein. The lane marked  lacked E1DBD in the binding reaction. (B) The total of bound complexes for each sample in panel A was quantitated with a PhosphorImager and plotted as a function of protein amount.

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

Papillomavirus E1 proteins are absolutely critical for initiation of viral DNA replication, serving as both origin recognition factors and helicases (36, 39, 41, 42, 44, 45). While several functional domains of E1 proteins have been defined (21, 25, 45), little is known about the actual three-dimensional structure of these proteins. Definition of the primary, secondary, and tertiary structures required for various biochemical activities and molecular interactions will be essential for understanding how initiation complexes assemble on the viral origin. Previously we showed that the DBD of BPV E1 is functional as an isolated polypeptide of approximately 190 amino acids (21). The E1DBD protein specifically recognizes the E1BS sequence in origin DNA fragments in vitro and also interacts with the viral E2 protein (21). A subsequent study with a slightly smaller E1DBD confirmed these properties and also demonstrated cooperative origin binding between the E1DBD and both full-length E2 and the E2DBD (7). The ability of the isolated E1DBD to function in origin recognition and E2 interaction in the same fashion as full-length E1 enables studies of E1-DNA interactions to be performed with this smaller molecule that is more easily expressed, purified, and analyzed.

In this study we examined predicted HRs of the E1DBD as potential molecular surface tracts that might be directly involved in DNA contact. The BPV E1DBD has three major HRs, two of which, HR1 (BPV E1 amino acids 179 to 191) and HR3 (amino acids 241 to 252), are well conserved among papillomavirus E1 proteins. A previous mutational analysis showed that conserved basic residues in HR3 are critical for E1 DNA binding activity (39), and we now demonstrate a similar requirement for basic residues in HR1. In contrast, mutation of a lysine residue in nonconserved HR2 caused only a small decrease in origin binding activity, indicating that this hydrophilic region is not as important for E1-DNA interaction. Inspection of the HR1 sequence suggested that all three basic residues known to be required for DNA binding could be physically juxtaposed on the helical face. Consistent with this prediction, mutation of T187 located on the same predicted face as the basic residues produced an E1DBD protein severely impaired for sequence-specific DNA binding in vitro. In contrast, the adjacent T188 residue is predicted to be on the opposing helical face, and its mutation had a relatively small effect on DNA binding activity. Likewise, mutation of a conserved residue on the same face as T188, D185, also resulted in a protein that was substantially more active than the T187A mutant. From these results, residue D185 is clearly not as critical for DNA binding as those on the hydrophilic helical face, though its high conservation suggests that it may function in some other E1 activity. While the actual secondary structure of HR1 is unknown, these mutational results support the existence of a hydrophilic face including at least four residues critical for E1 DNA binding function: R180, K183, K186, and T187.

In the absence of crystallographic or spectroscopic data on the structure of E1, it is useful to compare E1 with the simian virus 40 (SV40) large T antigen, with which it shares sequence and functional homology (9, 26). Even though these two proteins recognize completely different nucleotide sequences, there are some intriguing parallels to their DBDs (Fig. 8). First, their DBDs are of similar size, and each comprises a relatively small portion of the full-length protein: approximately 130 amino acids out of 708 for SV40 T antigen (20, 28) versus approximately 170 out of 605 for E1 (7, 21). (Note that the boundaries for the E1DBD might actually be even slightly smaller, as they have not been precisely defined.) Furthermore, the two DBDs are located in similar positions in the primary sequences, both beginning approximately 130 to 140 amino acids from the N terminus. Mutational analysis of T antigen defined two sets of critical amino acids for specific origin DNA binding, regions A (residues 152 to 155) and B2 (residues 203 to 207) (37, 43). Recent solution nuclear magnetic resonance studies on the isolated T-antigen DBD indicate that the A and B2 elements form a juxtaposed surface region that is the likely pentanucleotide contact site (23). Our present results, combined with those of Thorner et al. (39), identify two separate regions necessary for E1 binding activity, HR1 and HR3. HR1 and HR3 are separated by 49 intervening residues, compared to 47 amino acids between T-antigen regions A and B2. These similarities in organization of the DBDs for T antigen and E1 suggest that they could possess related three-dimensional structures. As the T-antigen DBD structure shares folding features with the DBDs of papillomavirus E2 proteins and the Epstein-Barr virus nuclear antigen 1 (10, 23), the E1DBD may also be part of this superfamily.

View larger version (12K): [in this window] [in a new window]   FIG. 8.   Organization of the DBD regions of SV40 large T antigen and BPV E1. The DBD domains of each protein are shaded, and the ATPase regions are striped. Within the DBDs, the open rectangles labeled A and B2 for T antigen and HR1 and HR2 for E1 indicate the locations of sequence regions critical for DNA binding activity (see text for details). The double-headed arrows between the open rectangles represent the similar spacing of approximately 50 amino acids in both proteins. Numbers refer to amino acids of each protein.

In addition to the in vitro DNA binding studies, a yeast one-hybrid system was developed to assay E1-DNA interactions in vivo. The full-length E1 protein exhibited site-specific DNA binding activity, which is the first direct demonstration that the minimal 18-bp E1BS sequence is sufficient to mediate E1-DNA interaction in the environment of the host cell nucleus. Given the relatively modest sequence specificity of E1 protein in vitro (32), the ability of E1 to locate and specifically bind the E1BS in the background of the yeast genome, and in the absence of E2 protein, was initially somewhat surprising. While the yeast genome is approximately 250-fold smaller than mammalian genomes, the absolute ratio of total nuclear DNA to E1BS DNA in the yeast strain is still at least a 1,000-fold larger than the ratio of competitor DNA to E1BS DNA that will prevent E1 binding in vitro (32). One factor that may facilitate the in vivo binding of E1 is that the E1BS sequence in the E1BST-LACZ reporter strain is a tandem triplet which should provide a higher local concentration of the target sequences. A second factor is that much of the vast excess of nuclear DNA may be inaccessible due to association with histones and host cell regulatory proteins, while the promoter region would naturally be more available. Because of this uncertainty in the actual amount of functional competitor, it is difficult to make quantitative comparisons between the in vivo and in vitro binding results.

Like the full-length E1 protein, the E1DBD specifically interacted with the E1BS in the one-hybrid system. These results confirmed that this in vitro-defined DBD domain is also stable and functional in vivo. The activity of the E1DBD in the yeast system allowed us to examine the role of HR1 in vivo. Mutation of K183 in HR1 severely impaired binding by the AD-E1DBD fusion, demonstrating that this region is as essential in vivo as it was in vitro. Furthermore, mutations in HR1 are the most frequently obtained clones when the one-hybrid system is used to screen for randomly generated mutants lacking DNA binding activity (M. West, unpublished data). In contrast to the K183A mutant, the K157A mutant was equivalent to WT both in vitro and in vivo. The concordance between the in vitro and in vivo binding activities indicates that the in vitro defects in binding are not simply the result of reduced stability of the mutant proteins during extraction and purification and instead represent intrinsic properties of the proteins. Overall, our results strongly implicate HR1 as a critical element for origin-specific binding by E1 protein and, by analogy with SV40 T antigen, suggest that the HR1 comprises at least part of the recognition sequence.